# Combined Rg3-enriched Korean Red Ginseng and American Ginseng in the Management of Hypertension in Type 2 Diabetes

> **NCT01578837** · PHASE1,PHASE2 · COMPLETED · sponsor: **Unity Health Toronto** · enrollment: 90 (estimated)

## Conditions studied

- Diabetes Mellitus Type 2
- Hypertension

## Interventions

- **DIETARY_SUPPLEMENT:** Ginseng
- **DIETARY_SUPPLEMENT:** Wheat Bran

## Key facts

- **NCT ID:** NCT01578837
- **Lead sponsor:** Unity Health Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2017-09
- **Final completion:** 2017-09
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2018-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01578837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01578837, "Combined Rg3-enriched Korean Red Ginseng and American Ginseng in the Management of Hypertension in Type 2 Diabetes". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01578837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*